CareMetx

Tommy G. Thompson serves as Chairman. Thompson is the former U.S. Secretary of Health and Human Services and a four-term Governor of Wisconsin, bringing deep regulatory and payer-policy expertise to the firm's governance.

CareMetx manages the full patient access journey for specialty drugs, which are often biologics or high-cost therapies. This includes verifying insurance benefits, securing prior authorizations from payers, enrolling patients in manufacturer assistance programs, and providing ongoing adherence support to ensure patients stay on therapy. The service aims to reduce the administrative abandonment rate—patients who never start a prescribed therapy due to access hurdles.

CareMetx is an operating company in the healthcare services sector, not a family office or investment fund. It functions as a specialized outsourced partner for pharmaceutical companies. Its revenue model is service-based, derived from contracts with drug manufacturers seeking to improve patient access and commercial outcomes.

The firm's platform is designed for complex specialty therapies, which public records indicate include oncology, rare diseases, immunology, and other chronic conditions requiring expensive drugs distributed through specialty pharmacies and limited distribution networks.

Yes, CareMetx employs case managers and patient access specialists who coordinate directly with patients and caregivers. This direct interaction is central to the hub model: fielding calls, identifying coverage gaps, finding financial assistance, and navigating the practical steps required to get a patient on and remaining on a prescribed treatment.